| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |